Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)
Clinical trial NCT03152019 · COMPLETED
Trial details
- NCT number
- NCT03152019
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2018-11-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.